Accordingly, our preclinical animal model will provide evidence and options for future evaluations of small-molecule inhibitors of PACE4 or their combined use with chemotherapy in the treatment of liver metastasis in pancreatic cancer. Here, PCSK6 is linked to familial pancreatic carcinoma.